When Failure Is Not Fatal: Examining Venture Resource Acquisition Following Product Development Failure

Abstract

Product development in innovation-driven industries often fails. Although such failures cause new ventures to struggle to raise follow-on investments, some overcome this challenge. Why? Synthesizing insights from the research on signaling and social evaluation theory, we identify how certain resources can mitigate the risk of funding termination for new ventures despite product development failure. Through a longitudinal study of 254 venture capital-funded biotechnology ventures, we show that internal quality signals decrease in their effectiveness while industry endorsement signals increase in their effectiveness as quality signals over time. Our findings contribute to the literatures on entrepreneurial failure, entrepreneurial resource acquisition and signaling.

Keywords

product development failures entrepreneurial resource acquisition social evaluation signaling entrepreneurial failure

Get full access to this article

View all access options for this article.

References

Abrantes-Metz

R. M.

Adams

Metz

(2005). Pharmaceutical development phases: A duration analysis. Journal of Pharmaceutical Finance, Economics, and Policy, 14, 19–41.

Adegbesan

J. A.

Higgins

M. J.

(2011). The intra-alliance division of value created through collaboration. Strategic Management Journal, 32(2), 187–211.

Aldrich

(1999). Organizations evolving. Sage.

Alsos

G. A.

Ljunggren

(2017). The role of gender in entrepreneur–investor relationships: A signaling theory approach. Entrepreneurship Theory and Practice, 41(4), 567–590.

Anderson

R. J.

(2019). Viagra: From NO to yes. The Pharmacologist, 61(2), 94–104.

Aspelund

Berg-Utby

Skjevdal

(2005). Initial resources’ influence on new venture survival: A longitudinal study of new technology-based firms. Technovation, 25(11), 1337–1347.

Bafera

Kleinert

(2023). Signaling theory in entrepreneurship research: A systematic review and research agenda. Entrepreneurship Theory and Practice, 47(6), 2419–2464.

Bamford

C. E.

Dean

T. J.

McDougall

P. P.

(2000). An examination of the impact of initial founding conditions and decisions upon the performance of new bank start-ups. Journal of Business Venturing, 15(3), 253–277.

Basu

Phelps

Kotha

(2011). Towards understanding who makes corporate venture capital investments and why. Journal of Business Venturing, 26(2), 153–171.

10.

Baum

C. F.

Schaffer

M. E.

Stillman

(2003). Instrumental variables and GMM: Estimation and testing. The Stata Journal, 3(1), 1–31.

11.

Benson

Ziedonis

R. H.

(2009). Corporate venture capital as a window on new technologies: Implications for the performance of corporate investors when acquiring startups. Organization Science, 20(2), 329–351.

12.

Bergh

D. D.

Connelly

B. L.

Ketchen

D. J.

Jr. Shannon

L. M.

(2014). Signalling theory and equilibrium in strategic management research: An assessment and a research agenda. Journal of Management Studies, 51(8), 1334–1360.

13.

Blossfeld

H. P.

Rohwer

(1995). Techniques of event history modeling. Erlbaum.

14.

Booth

(2011). Risky business: Late stage vs early stage biotech. https://lifescivc.com/2011/11/risky-business-late-stage-vs-early-stage-biotech/

15.

Booth

(2017). Distinctive corporate culture in biotech: Walk the talk. Forbes.

16.

Box-Steffensmeier

J. M.

Jones

B. S.

(2004). Event history modeling: A guide for social scientists: Cambridge University Press.

17.

Box-Steffensmeier

J. M.

Zorn

(2002). Duration models for repeated events. Journal of Politics, 64(4), 1069–1094.

18.

Bruderl

Schussler

(1990). Organizational mortality: The liabilities of newness and adolescence. Administrative Science Quarterly, 35(3), 530–547.

19.

Bundy

Pfarrer

M. D.

Short

C. E.

Coombs

W. T.

(2017). Crises and crisis management: Integration, interpretation, and research development. Journal of Management, 43(6), 1661–1692.

20.

Busenbark

J. R.

Yoon

Gamache

D. L.

Withers

M. C.

(2022). Omitted variable bias: Examining management research with the impact threshold of a confounding variable (ITCV). Journal of Management, 48(1), 17–48.

21.

Cardinal

L. B.

(2001). Technological innovation in the pharmaceutical industry: The use of organizational control in managing research and development. Organization Science, 12(1), 19–36.

22.

Ceccagnoli

Higgins

M. J.

Kang

H. D.

(2018). Corporate venture capital as a real option in the markets for technology. Strategic Management Journal, 39(13), 3355–3381.

23.

Cheng

J. L.

Kesner

I. F.

(1997). Organizational slack and response to environmental shifts: The impact of resource allocation patterns. Journal of Management, 23(1), 1–18.

24.

Colombo

M. G.

Grilli

(2010). On growth drivers of high-tech start-ups: Exploring the role of founders’ human capital and venture capital. Journal of Business Venturing, 25(6), 610–626.

25.

Colombo

(2021). The use of signals in new-venture financing: A review and research agenda. Journal of Management, 47(1), 237–259.

26.

Connelly

B. L.

Certo

S. T.

Ireland

R. D.

Reutzel

C. R.

(2011). Signaling theory: A review and assessment. Journal of Management, 37(1), 39–67.

27.

Cox

D. R.

(1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202.

28.

Cyert

R. M.

March

J. G

. (1963). A behavioral theory of the firm. Prentice Hall.

29.

Dacin

M. T.

Oliver

Roy

J. P.

(2007). The legitimacy of strategic alliances: An institutional perspective. Strategic Management Journal, 28(2), 169–187.

30.

De Carolis

D. M.

Yang

Deeds

D. L.

Nelling

. (2009). Weathering the storm: The benefit of resources to high-technology ventures navigating adverse events. Strategic Entrepreneurship Journal, 3(2), 147–160.

31.

Deeds

D. L.

(2001). The role of R&D intensity, technical development and absorptive capacity in creating entrepreneurial wealth in high technology start-ups. Journal of Engineering and Technology Management, 18(1), 29–47.

32.

Deegan

P. B.

Cox

T. M.

(2012). Imiglucerase in the treatment of Gaucher disease: A history and perspective. Drug Design Development and Therapy, 6, 81–106.

33.

Devers

C. E.

Dewett

Mishina

Belsito

C. A.

(2009). A general theory of organizational stigma. Organization Science, 20(1), 154–171.

34.

Diestre

Rajagopalan

(2012). Are all “sharks” dangerous? New biotechnology ventures and partner selection in R&D alliances. Strategic Management Journal, 33(10), 1115–1134.

35.

DiMasi

J. A.

Grabowski

H. G.

Hansen

R. W.

(2016). Innovation in the pharmaceutical industry: New estimates of R&D costs. Journal of Health Economics, 47, 20–33.

36.

Dorobantu

Henisz

W. J.

Nartey

(2017). Not all sparks light a fire: Stakeholder and shareholder reactions to critical events in contested markets. Administrative Science Quarterly, 62(3), 561–597.

37.

Drover

Wood

M. S.

Corbett

A. C.

(2018). Toward a cognitive view of signalling theory: Individual attention and signal set interpretation. Journal of Management Studies, 55(2), 209–231.

38.

Eggers

Park

K. F.

(2018). Incumbent adaptation to technological change: The past, present, and future of research on heterogeneous incumbent response. Academy of Management Annals, 12(1), 357–389.

39.

Eggers

J. P.

Suh

J.-H.

(2019). Experience and behavior: How negative feedback in new versus experienced domains affects firm action and subsequent performance. Academy of Management Journal, 62(2), 309–334.

40.

Eisenhardt

K. M.

Schoonhoven

C. B.

(1990). Organizational growth: Linking founding team, strategy, environment, and growth among US semiconductor ventures, 1978–1988. Administrative Science Quarterly, 35(3), 504–529.

41.

Fichman

Levinthal

D. A.

(1991). Honeymoons and the liability of adolescence: A new perspective on duration dependence in social and organizational relationships. Academy of Management Review, 16(2), 442–468.

42.

Fine

J. P.

Gray

R. J.

(1999). A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association, 94(446), 496–509.

43.

Fini

Jourdan

Perkmann

(2018). Social valuation across multiple audiences: The interplay of ability and identity judgments. Academy of Management Journal, 61(6), 2230–2264.

44.

Fisher

Kotha

Lahiri

(2016). Changing with the times: An integrated view of identity, legitimacy, and new venture life cycles. Academy of Management Review, 41(3), 383–409.

45.

Fisher

Kuratko

D. F.

Bloodgood

J. M.

Hornsby

J. S.

(2017). Legitimate to whom? The challenge of audience diversity and new venture legitimacy. Journal of Business Venturing, 32(1), 52–71.

46.

Franke

Gruber

Harhoff

Henkel

(2008). Venture capitalists’ evaluations of start–up teams: Trade–offs, knock–out criteria, and the impact of VC experience. Entrepreneurship Theory and Practice, 32(3), 459–483.

47.

Furr

N. R.

(2019). Product adaptation during new industry emergence: The role of start-up team preentry experience. Organization Science, 30(5), 1076–1096.

48.

Galaskiewicz

Wasserman

(1989). Mimetic processes within an interorganizational field: An empirical test. Administrative Science Quarterly, 34(3), 454–479.

49.

Gans

J. S.

Stern

(2003). The product market and the market for “ideas”: Commercialization strategies for technology entrepreneurs. Research Policy, 32(2), 333–350.

50.

Gerasymenko

De Clercq

Sapienza

H. J.

(2015). Changing the business model: Effects of venture capital firms and outside CEOs on portfolio company performance. Strategic Entrepreneurship Journal, 9(1), 79–98.

51.

Gersick

C. J.

(1994). Pacing strategic change: The case of a new venture. Academy of Management Journal, 37(1), 9–45.

52.

Gillespie

Dietz

(2009). Trust repair after an organization-level failure. The Academy of Management Review, 34(1), 127–145.

53.

Girotra

Terwiesch

Ulrich

K. T.

(2007). Valuing R&D projects in a portfolio: Evidence from the pharmaceutical industry. Management Science, 53(9), 1452–1466.

54.

Gompers

Lerner

(2001). The venture capital revolution. Journal of Economic Perspectives, 15(2), 145–168.

55.

Gompers

P. A.

Gornall

Kaplan

S. N.

Strebulaev

I. A.

(2020). How do venture capitalists make decisions? Journal of Financial Economics, 135(1), 169–190.

56.

Gomulya

Mishina

(2017). Signaler credibility, signal susceptibility, and relative reliance on signals: How stakeholders change their evaluative processes after violation of expectations and rehabilitative efforts. Academy of Management Journal, 60(2), 554–583.

57.

Gorman

Sahlman

W. A.

(1989). What do venture capitalists do? Journal of Business Venturing, 4(4), 231–248.

58.

Graves

S. B.

Ringuest

(2018). Overconfidence and disappointment in venture capital decision making: An empirical examination. Managerial and Decision Economics, 39(5), 592–600.

59.

Gruber

MacMillan

I. C.

Thompson

J. D.

(2013). Escaping the prior knowledge corridor: What shapes the number and variety of market opportunities identified before market entry of technology start-ups? Organization Science, 24(1), 280–300.

60.

Guler

(2007). Throwing good money after bad? Political and institutional influences on sequential decision making in the venture capital industry. Administrative Science Quarterly, 52(2), 248–285.

61.

Hallen

B. L.

(2008). The causes and consequences of the initial network positions of new organizations: From whom do entrepreneurs receive investments? Administrative Science Quarterly, 53(4), 685–718.

62.

Hannan

M. T.

(1998). Rethinking age dependence in organizational mortality: Logical fromalizations. American Journal of Sociology, 104(1), 126–164.

63.

Harrison

J. S.

Boivie

Sharp

N. Y.

Gentry

R. J.

(2018). Saving face: How exit in response to negative press and star analyst downgrades reflects reputation maintenance by directors. Academy of Management Journal, 61(3), 1131–1157.

64.

Harrison

R. T.

Mason

C. M.

(2017). Backing the horse or the jockey? Due diligence, agency costs, information and the evaluation of risk by business angel investors. International Review of Entrepreneurship, 15(3), 269–290.

65.

Haunschild

P. R.

Sullivan

B. N.

(2002). Learning from complexity: Effects of prior accidents and incidents on airlines’ learning. Administrative Science Quarterly, 47(4), 609–643.

66.

Hite

J. M.

Hesterly

W. S.

(2001). The evolution of firm networks: From emergence to early growth of the firm. Strategic Management Journal, 22(3), 275–286.

67.

Hoang

Rothaermel

F. T.

(2010). Leveraging internal and external experience: Exploration, exploitation, and R&D project performance. Strategic Management Journal, 31(7), 734–758.

68.

Hoenen

Kolympiris

Schoenmakers

Kalaitzandonakes

(2014). The diminishing signaling value of patents between early rounds of venture capital financing. Research Policy, 43(6), 956–989.

69.

Hoenig

Henkel

(2015). Quality signals? The role of patents, alliances, and team experience in venture capital financing. Research Policy, 44(5), 1049–1064.

70.

Hsu

D. H.

(2007). Experienced entrepreneurial founders, organizational capital, and venture capital funding. Research Policy, 36(5), 722–741.

71.

Hsu

D. H.

Ziedonis

R. H.

(2013). Resources as dual sources of advantage: Implications for valuing entrepreneurial-firm patents. Strategic Management Journal, 34(7), 761–781.

72.

Huang

(2018). The role of investor gut feel in managing complexity and extreme risk. Academy of Management Journal, 61(5), 1821–1847.

73.

Huang

Knight

A. P.

(2017). Resources and relationships in entrepreneurship: An exchange theory of the development and effects of the entrepreneur-investor relationship. Academy of Management Review, 42(1), 80–102.

74.

Janney

J. J.

Folta

T. B.

(2003). Signaling through private equity placements and its impact on the valuation of biotechnology firms. Journal of Business Venturing, 18(3), 361–380.

75.

Kaplan

S. N.

Sensoy

B. A.

Stromberg

(2009). Should investors bet on the jockey or the horse ? Evidence from the evolution of firms from early business plans to public companies. Journal of Finance, 64(1), 75–115.

76.

Kapoor

Klueter

(2015). Decoding the adaptability–rigidity puzzle: Evidence from pharmaceutical incumbents’ pursuit of gene therapy and monoclonal antibodies. Academy of Management Journal, 58(4), 1180–1207.

77.

Katila

Rosenberger

J. D.

Eisenhardt

K. M.

(2008). Swimming with sharks: Technology ventures, defense mechanisms and corporate relationships. Administrative Science Quarterly, 53(2), 295–332.

78.

Kazanjian

R. K.

(1988). Relation of dominant problems to stages of growth in technology-based new ventures. Academy of Management Journal, 31(2), 257–279.

79.

Keil

Maula

M. V.

Wilson

(2010). Unique resources of corporate venture capitalists as a key to entry into rigid venture capital syndication networks. Entrepreneurship Theory and Practice, 34(1), 83–103.

80.

Khanna

Guler

Nerkar

(2016). Fail often, fail big, and fail fast? Learning from small failures and R&D performance in the pharmaceutical industry. Academy of Management Journal, 59(2), 436–459.

81.

Kistruck

G. M.

Webb

J. W.

Sutter

C. J.

Bailey

A. V.

(2015). The double-edged sword of legitimacy in base-of-the-pyramid markets. Journal of Business Venturing, 30(3), 436–451.

82.

E.-J.

McKelvie

(2018). Signaling for more money: The roles of founders’ human capital and investor prominence in resource acquisition across different stages of firm development. Journal of Business Venturing, 33(4), 438–454.

83.

Lee

P. M.

(2001). What’s in a name. com?: The effects of “. com”name changes on stock prices and trading activity. Strategic Management Journal, 22(8), 793–804.

84.

Lee

P. M.

Wahal

(2004). Grandstanding, certification and the underpricing of venture capital backed IPOs. Journal of Financial Economics, 73(2), 375–407.

85.

Lev

(2001). Intangibles: Management, measurement and reporting. Brookings Institution Press.

86.

G.-C.

Lai

D’Amour

Doolin

D. M.

Sun

Torvik

V. I.

A. Z.

Fleming

(2014). Disambiguation and co-authorship networks of the US patent inventor database (1975–2010). Research Policy, 43(6), 941–955.

87.

Lichtenstein

B. M. B.

Brush

C. G.

(2001). How do “resource bundles” develop and change in new ventures? A dynamic model and longitudinal exploration. Entrepreneurship Theory and Practice, 25(3), 37–58.

88.

Lin

Yang

Arya

(2009). Alliance partners and firm performance: Resource complementarity and status association. Strategic Management Journal, 30(9), 921–940.

89.

Love

E. G.

Kraatz

(2009). Character, conformity, or the bottom line? How and why downsizing affected corporate reputation. Academy of Management Journal, 52(2), 314–335.

90.

Madsen

P. M.

Desai

(2010). Failing to learn? The effects of failure and success on organizational learning in the global orbital launch vehicle industry. Academy of Management Journal, 53(3), 451–476.

91.

Marco

A. C.

Sarnoff

J. D.

deGrazia

C. A. W.

(2019). Patent claims and patent scope. Research Policy, 48(9), 103790.

92.

Marlow

Patton

(2005). All credit to men? Entrepreneurship, finance, and gender. Entrepreneurship Theory and Practice, 29(6), 717–735.

93.

Marvel

M. R.

Wolfe

M. T.

Kuratko

D. F.

(2020). Escaping the knowledge corridor: How founder human capital and founder coachability impacts product innovation in new ventures. Journal of Business Venturing, 35(6), 106060.

94.

Marx

Hsu

D. H.

(2015). Strategic switchbacks: Dynamic commercialization strategies for technology entrepreneurs. Research Policy, 44(10), 1815–1826.

95.

Mason

Stark

(2004). What do investors look for in a business plan? A comparison of the investment criteria of bankers, venture capitalists and business angels. International Small Business Journal, 22(3), 227–248.

96.

Maurer

Ebers

(2006). Dynamics of social capital and their performance implications: Lessons from biotechnology start-ups. Administrative Science Quarterly, 51(2), 262–292.

97.

Mc Namara

Baden-Fuller

. (2007). Shareholder returns and the exploration–exploitation dilemma: R&D announcements by biotechnology firms. Research Policy, 36(4), 548–565.

98.

McDonald

Gao

(2019). Pivoting isn’t enough? Managing strategic reorientation in new ventures. Organization Science, 30(6), 1289–1318.

99.

Miloud

Aspelund

Cabrol

(2012). Startup valuation by venture capitalists: An empirical study. Venture Capital, 14(2–3), 151–174.

100.

Miner

A. S.

Amburgey

T. L.

Stearns

T. M.

(1990). Interorganizational linkages and population dynamics: Buffering and transformational shields. Administrative Science Quarterly, 35(4), 689–713.

101.

Mishina

Block

E. S.

Mannor

M. J.

(2012). The path dependence of organizational reputation: How social judgment influences assessments of capability and character. Strategic Management Journal, 33(5), 459–477.

102.

Mitteness

C. R.

Baucus

M. S.

Sudek

(2012). Horse vs. Jockey? How stage of funding process and industry experience affect the evaluations of angel investors. Venture Capital, 14(4), 241–267.

103.

Nahapiet

Ghoshal

(1998). Social capital, intellectual capital, and the organizational advantage. Academy of Management Review, 23(2), 242–266.

104.

Pahnke

E. C.

Katila

Eisenhardt

K. M.

(2015). Who takes you to the dance? How partners’ institutional logics influence innovation in young firms. Administrative Science Quarterly, 60(4), 596–633.

105.

Park

Rogan

(2019). Capability reputation, character reputation, and exchange partners’ reactions to adverse events. Academy of Management Journal, 62(2), 553–578.

106.

Parker

Krause

Devers

C. E.

(2019). How firm reputation shapes managerial discretion. Academy of Management Review, 44(2), 254–278.

107.

Patzelt

Preller

Breugst

(2021). Understanding the life cycles of entrepreneurial teams and their ventures: An agenda for future research. Entrepreneurship Theory and Practice, 45(5), 1119–1153.

108.

Petkova

A. P.

Wadhwa

Yao

Jain

(2014). Reputation and decision making under ambiguity: A study of US venture capital firms’ investments in the emerging clean energy sector. Academy of Management Journal, 57(2), 422–448.

109.

Pharmaceutical Research and Manufacturers of America (PhRMA). (2016). Biopharmaceutical research industry profile. Pharmaceutical Research and Manufacturers of America.

110.

Pisano

G. P.

(1991). The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry. Research Policy, 20(3), 237–249.

111.

Pisano

G. P.

(2010). The evolution of science-based business: Innovating how we innovate. Industrial and Corporate Change, 19(2), 465–482.

112.

Plummer

L. A.

Allison

T. H.

Connelly

B. L.

(2016). Better together? Signaling interactions in new venture pursuit of initial external capital. Academy of Management Journal, 59(5), 1585–1604.

113.

Pollock

T. G.

Lashley

Rindova

V. P.

Han

J.-H.

(2019). Which of these things are not like the others? Comparing the rational, emotional, and moral aspects of reputation, status, celebrity, and stigma. Academy of Management Annals, 13(2), 444–478.

114.

Pollock

T. G.

Rindova

V. P.

(2003). Media legitimation effects in the market for initial public offerings. Academy of Management Journal, 46(5), 631–642.

115.

Rawhouser

Villanueva

Newbert

S. L.

(2017). Strategies and tools for entrepreneurial resource access: A cross-disciplinary review and typology. International Journal of Management Reviews, 19(4), 473–491.

116.

Roccapriore

A. Y.

Imhof

Cardon

M. S.

(2021). Badge of honor or tolerable reality? How previous firm failure and experience influences investor perceptions. Journal of Business Venturing Insights, 16, e00252.

117.

Rossi

Vanacker

Vismara

(2023). Unsuccessful equity crowdfunding offerings and the persistence in equity fundraising of family business start-ups. Entrepreneurship Theory and Practice, 47(4), 1327–1355.

118.

Rothaermel

F. T.

Deeds

D. L.

(2004). Exploration and exploitation alliances in biotechnology: A system of new product development. Strategic Management Journal, 25(3), 201–221.

119.

Schilling

M. A.

(2015). Towards dynamic efficiency: Innovation and its implications for antitrust. The Antitrust Bulletin, 60(3), 191–207.

120.

Schoonhoven

C. B.

Eisenhardt

K. M.

Lyman

(1990). Speeding products to market: Waiting time to first product introduction in new firms. Administrative Science Quarterly, 35(1), 177–207.

121.

Schumpeter

(1934). The theory of economic development. Springer.

122.

Shane

Cable

(2002). Network ties, reputation, and the financing of new ventures. Management Science, 48(3), 364–381.

123.

Shane

Stuart

(2002). Organizational endowments and the performance of university start-ups. Management Science, 48(1), 154–170.

124.

Shepherd

D. A.

(2020). COVID 19 and entrepreneurship: Time to pivot? Journal of Management Studies, 57(8), 1750–1753.

125.

Snihur

Clarysse

(2022). Sowing the seeds of failure: Organizational identity dynamics in new venture pivoting. Journal of Business Venturing, 37(1), 106164.

126.

Souakri

Coeurderoy

Zacharakis

(2022). Valuing failure: An experiment of VC reactions to an entrepreneur’s record of business creation. Journal of Small Business Management, 61(5), 2350–2381.

127.

Spence

(1973). Job market signaling. The Quarterly Journal of Economics, 87(3), 355–374.

128.

Spence

(2002). Signaling in retrospect and the informational structure of markets. American Economic Review, 92(3), 434–459.

129.

Stevenson

Allen

Wang

(2022). Failed but validated? The effect of market validation on persistence and performance after a crowdfunding failure. Journal of Business Venturing, 37(2), 106175.

130.

Stuart

T. E.

(1998). Network positions and propensities to collaborate: An investigation of strategic alliance formation in a high-technology industry. Administrative Science Quarterly, 43(3), 668–698.

131.

Stuart

T. E.

Hoang

Hybels

R. C.

(1999). Interorganizational endorsements and the performance of entrepreneurial ventures. Administrative Science Quarterly, 44(2), 315–349.

132.

Suzuki

(2018). Enabling or constraining? Unraveling the influence of organizational slack on innovation. Industrial and Corporate Change, 27(3), 555–575.

133.

Urbig

Bürger

Patzelt

Schweizer

(2013). Investor reactions to new product development failures:The moderating role of product development stage. Journal of Management, 39(4), 985–1015.

134.

Vanacker

Forbes

D. P.

(2016). Disentangling the multiple effects of affiliate reputation on resource attraction in new firms. Organization Science, 27(6), 1525–1547.

135.

Vittinghoff

McCulloch

C. E.

(2007). Relaxing the rule of ten events per variable in logistic and Cox regression. American Journal of Epidemiology, 165(6), 710–718.

136.

Washington

Zajac

E. J.

(2005). Status evolution and competition: Theory and evidence. Academy of Management Journal, 48(2), 282–296.

137.

Welter

(2011). Contextualizing entrepreneurship—Conceptual challenges and ways forward. Entrepreneurship Theory and Practice, 35(1), 165–184.

138.

Welter

Baker

Audretsch

D. B.

Gartner

W. B.

(2017). Everyday entrepreneurship—A call for entrepreneurship research to embrace entrepreneurial diversity. Entrepreneurship Theory and Practice, 41(3), 311–321.

139.

Wenzel

Stanske

Lieberman

M. B.

(2021). Strategic responses to crisis. Strategic Management Journal, 42(2), O16–O27.

140.

Wiklund

Shepherd

(2003). Knowledge-based resources, entrepreneurial orientation, and the performance of small and medium-sized businesses. Strategic Management Journal, 24(13), 1307–1314.

141.

Frank

K. A.

Maroulis

S. J.

Rosenberg

J. M.

(2019). Konfound: Command to quantify robustness of causal inferences. The Stata Journal, 19(3), 523–550.

142.

Zacharakis

A. L.

Shepherd

D. A.

(2001). The nature of information and overconfidence on venture capitalists’ decision making. Journal of Business Venturing, 16(4), 311–332.

143.

Zimmerman

M. A.

(2008). The influence of top management team heterogeneity on the capital raised through an initial public offering. Entrepreneurship Theory and Practice, 32(3), 391–414.

144.

Zuckerman

E. W.

(2012). Construction, concentration, and (dis) continuities in social valuations. Annual Review of Sociology, 38(1), 223–245.

145.

Zunino

Dushnitsky

Van Praag

(2022). How do investors evaluate past entrepreneurial failure? Unpacking failure due to lack of skill versus bad luck. Academy of Management Journal, 65(4), 1083–1109.